In a report released yesterday, Charlie CY Yang from Bank of America Securities reiterated a Buy rating on Royalty Pharma (RPRX – Research ...
The drug, called icotrokinra and developed together with Protagonist Therapeutics, is an oral peptide designed to tamp down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback